Prediction of pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy using baseline 18F-FDG PET/CT-derived CT radiomics and clinicopathological biomarkers

Filiz Hatipoglu, Ozcan Senmevsim, E. Gokhan Kahraman, Funda Tasli

Open source

DOI
10.1097/mnm.0000000000002258
Published
2026-11-03
Container
Nuclear Medicine Communications
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/mnm.0000000000002258,
  title = {Prediction of pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy using baseline 18F-FDG PET/CT-derived CT radiomics and clinicopathological biomarkers},
  author = {Filiz Hatipoglu and Ozcan Senmevsim and E. Gokhan Kahraman and Funda Tasli},
  year = {2026},
  journal = {Nuclear Medicine Communications},
  doi = {10.1097/mnm.0000000000002258},
  url = {https://doi.org/10.1097/mnm.0000000000002258}
}

RIS

TY  - JOUR
TI  - Prediction of pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy using baseline 18F-FDG PET/CT-derived CT radiomics and clinicopathological biomarkers
AU  - Filiz Hatipoglu
AU  - Ozcan Senmevsim
AU  - E. Gokhan Kahraman
AU  - Funda Tasli
PY  - 2026
JO  - Nuclear Medicine Communications
DO  - 10.1097/mnm.0000000000002258
UR  - https://doi.org/10.1097/mnm.0000000000002258
ER  - 

APA

Hatipoglu, F., Senmevsim, O., Kahraman, E. G., & Tasli, F. (2026). Prediction of pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy using baseline 18F-FDG PET/CT-derived CT radiomics and clinicopathological biomarkers. Nuclear Medicine Communications. https://doi.org/10.1097/mnm.0000000000002258

Source records